RE: Rns - strategy update8 May 2026 07:05
The Board's initial assessment of Physiomics' balance sheet is that there is a sufficient cash runway into 2027. Following its initial assessment, the Board believes there is a substantial opportunity to enhance operations, optimise resources, and improve commercial delivery while maintaining the Company's scientific credibility and client service standards.